A paradigm change in the treatment of blinding ocular diseases

Project Information

TRS

Grant agreement ID: 879598

DOI 10.3030/879598

Project closed

EC signature date 3 September 2019

Start date 1 July 2019

End date 30 June 2021

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost € 3 461 500,00

EU contribution € 2 423 050,00

Coordinated by

TARSIER PHARMA LTD
Israel